Optimizing the dasatinib dose regimen in chronic phase chronic myeloid leukemia: 100 mg once daily available for use

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{4a39d3ffd871420dbf5bef8d34a6aa74,

title = "Optimizing the dasatinib dose regimen in chronic phase chronic myeloid leukemia: 100 mg once daily available for use",

author = "Ravi Vij",

year = "2009",

month = jan,

doi = "10.1016/S1548-5315(11)70371-0",

language = "English",

volume = "6",

pages = "18--20",

journal = "Community Oncology",

issn = "1548-5315",

number = "1",

}

TY - JOUR

T1 - Optimizing the dasatinib dose regimen in chronic phase chronic myeloid leukemia

T2 - 100 mg once daily available for use

AU - Vij, Ravi

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=60049096308&partnerID=8YFLogxK

U2 - 10.1016/S1548-5315(11)70371-0

DO - 10.1016/S1548-5315(11)70371-0

M3 - Article

AN - SCOPUS:60049096308

SN - 1548-5315

VL - 6

SP - 18

EP - 20

JO - Community Oncology

JF - Community Oncology

IS - 1

ER -